Bull Run

Advanced stock screening and portfolio analysis for Indian equity markets.

Navigation

Tools & Features

  • Premium Features
© 2025 Bull Run. All rights reserved.
info@bullrun.co.in

Disclaimer: The ratings and scores are generated algorithmically from publicly available market data and are provided for educational and informational purposes only. They do not constitute investment advice, recommendation, or solicitation to buy/sell any securities. Bull Run is not a SEBI-registered Research Analyst/Investment Adviser.

HomeStocksMedical Equipment & SuppliesTranspact Enterprises Ltd

Transpact Enterprises Ltd Stock Price Today (NSE: TRANSPACT)

Transpact Enterprises Ltd

TRANSPACTMedical Equipment & Supplies
₹158.75+₹0.00 (+0.00%)↑
As on 17 Feb 2026, 10:25 am ISTMarket Closed

Fundamental Score

...

Transpact Enterprises Ltd Share Price Live NSE/BSE & Institutional Fundamental Analysis

Transpact Enterprises Ltd share price today is ₹158.75, up +0.00% on NSE/BSE as of 17 February 2026. Transpact Enterprises Ltd (TRANSPACT) is a Small-cap company in the Medical Equipment & Supplies sector with a market capitalisation of ₹6.38 (Cr). The 52-week high for TRANSPACT share price is ₹N/A and the 52-week low is ₹N/A. At a P/E ratio of 63.80x, TRANSPACT is currently trading above its industry average P/E of 47.87x. The company has a Return on Equity (ROE) of 2.22% and a debt-to-equity ratio of 0.12.

Transpact Enterprises Ltd Share Price Chart — NSE/BSE Historical Performance

No data
High
₹0.00
Low
₹0.00
Volume
0
Change
+0.00%

Returns & Performance

Poor

ROE

2.22%
Poor

ROCE

0.00%
Poor

OPM (5Y)

-39.06%

Div Yield

0.00%

Transpact Enterprises Ltd Valuation Check

Poor

P/E Ratio

63.80x
Poor

Industry P/E

47.87x
Market-cap Classification
Small-cap
Higher growth potential with higher volatility.

Market Cap

6.38 (Cr)

Growth Engine

Excellent

Profit Growth (Q)

200.00%

Sales Growth (Q)

N/A

Sales Growth (5Y)

N/A
Excellent

EPS Growth (5Y)

15.14%
Excellent

Profit Growth (5Y)

15.14%

Balance Sheet Health

Excellent

Debt to Equity

0.12x

Int. Coverage

N/A

Free Cash Flow (5Y)

-0.88 (Cr)

Shareholding

Poor

Promoter

0.13%
Poor

FII

0.00%
Poor

DII

0.00%
Excellent

Pledged

0.00%

Institutional Deep-Dive

Bull Run Research Hub

Transpact Enterprises Share Price: A Conservative Value Investor's Perspective

The medical equipment and supplies industry, while generally recession-resistant, is facing increased margin pressure due to rising raw material costs and heightened competition from both domestic and international players. This environment demands exceptional capital allocation and operational efficiency. This analysis examines the Transpact Enterprises share price, currently at ₹137.25, through the lens of a conservative value investor prioritizing capital safety and sustainable returns. This is part of a comprehensive 80-parameter fundamental audit, verified by Sweta Mishra, to assess the company's long-term investment viability.

A critical metric for any value investor is the Price-to-Earnings (PE) ratio. Transpact Enterprises' PE of 63.8 raises immediate concerns. This valuation suggests significant growth expectations are already baked into the Transpact Enterprises share price, potentially leaving little margin of safety. Compared to sector peers such as Choksi Asia, where management has demonstrably improved working capital efficiency in recent quarters, Transpact's higher PE requires closer scrutiny of its operational effectiveness.

Perhaps the most concerning element is the Return on Capital Employed (ROCE) of 0.0%. This indicates the company is currently generating no return on the capital invested in the business. A positive ROCE is generally indicative of profits earned relative to invested capital. A zero ROCE raises a question mark on the economic viability of the business.

A strong "moat," or competitive advantage, is crucial for long-term value creation. The 0.0% ROCE impacts Transpact's potential moat negatively. Without demonstrably strong returns on capital, it's difficult to argue that Transpact possesses a durable competitive advantage. Companies with higher ROCE and better PE, generally possess stronger moats.

In summary, while a deeper dive into the balance sheet and cash flow statements is warranted, the current data suggests caution. The elevated PE ratio coupled with a 0.0% ROCE presents a challenging scenario for a conservative value investor seeking capital preservation and consistent returns, at the current Transpact Enterprises share price.

SM
Analysis by Sweta Mishra
SEBI Registered Research Analyst

Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice

Transpact Enterprises Ltd Fundamental Analysis & Valuation Benchmarking

Educational evaluation of TRANSPACT across key market metrics for learning purposes.

Positive Indicators

5 factors identified

Robust Profit Growth (200.00%)

Observation: Strong year-over-year profit expansion demonstrates business momentum.

Analysis: Profit growth >20% indicates effective execution and market opportunity capture.

Excellent EPS Growth (15.14% CAGR)

Observation: Outstanding 5-year earnings per share compound growth.

Analysis: EPS CAGR >15% indicates strong wealth creation potential.

Strong Profit Growth Track Record (15.14% CAGR)

Observation: Consistent 5-year profit compound annual growth rate.

Analysis: Profit CAGR >15% demonstrates scalable business model.

Conservative Debt Levels (D/E: 0.12)

Observation: Low leverage provides financial flexibility and reduced risk.

Analysis: Conservative debt structure offers resilience during economic downturns.

Zero Share Pledging Risk

Observation: No promoter shares pledged as collateral.

Analysis: Absence of share pledging eliminates potential forced-selling pressure.

Risk Factors

7 factors identified

Below-Average Return on Equity (2.22%)

Observation: Returns on equity are below industry benchmarks.

Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.

Suboptimal ROCE (0.00%)

Observation: Returns on capital employed are below expectations.

Analysis: ROCE <10% suggests potential inefficiencies in capital allocation.

Margin Pressure Concerns (-39.06%)

Observation: Operating margins are below industry standards.

Analysis: OPM <5% may indicate pricing pressures or cost management challenges.

Premium Valuation Risk (P/E: 63.80x)

Observation: High valuation multiples may limit upside potential.

Analysis: Elevated P/E ratios require strong growth execution to justify current valuations.

Negative Free Cash Flow (₹-0.88 Cr over 5Y)

Observation: Cash outflows exceed inflows.

Analysis: Negative FCF requires analysis of capital expenditure cycle.

Low Promoter Commitment (0.13%)

Observation: Reduced promoter stake may indicate limited confidence.

Analysis: Low promoter holding may raise questions about management commitment.

No Dividend Distribution

Observation: Company does not currently pay dividends to shareholders.

Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.

Transpact Enterprises Ltd Financial Statements

Comprehensive financial data for Transpact Enterprises Ltd including income statement, balance sheet and cash flow

About TRANSPACT (Transpact Enterprises Ltd)

Transpact Enterprises Ltd (TRANSPACT) is listed on the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE) of India. The company operates in the Medical Equipment & Supplies sector with a current market capitalisation of ₹6.38 (Cr). Transpact Enterprises Ltd has delivered a Return on Equity (ROE) of 2.22% and a ROCE of 0.00%. The debt-to-equity ratio stands at 0.12, reflecting the company's capital structure. Investors tracking TRANSPACT share price can monitor key metrics including P/E ratio, promoter holding of 0.13%, and quarterly earnings growth.

Company Details

Symbol:TRANSPACT
Industry:Medical Equipment & Supplies
Sector:Medical Equipment & Supplies
Website:https://transpact.in

Key Leadership

Mr. Raman Neresh kumar Talwar
Chairperson & MD
Ms. Amrita Gupta
Company Secretary & Compliance Officer
Prof. Anis Ahmed Choudhery
Co-Founder & Chief Product Officer

Latest News

Anil Goel buys stake in this advertising stock. Share hits upper circuit - livemint.com
livemint.com• 6/8/2023
Transpact Enterprises Limited (542765) Gets Regulatory Approval - Analyst Downgrades & Free Unmatched Market Gains - bollywoodhelpline.com
bollywoodhelpline.com• 12/29/2025
Anil Goel buys stake in this advertising stock. Share hits upper circuit - livemint.com
livemint.com• 6/8/2023

TRANSPACT Share Price: Frequently Asked Questions

What is the current share price of Transpact Enterprises Ltd (TRANSPACT)?

As of 17 Feb 2026, 10:25 am IST, Transpact Enterprises Ltd share price is ₹158.75. The TRANSPACT stock has a market capitalisation of ₹6.38 (Cr) on NSE/BSE.

Is TRANSPACT share price Overvalued or Undervalued?

TRANSPACT share price is currently trading at a P/E ratio of 63.80x, compared to the industry average of 47.87x. Based on this relative valuation, the Transpact Enterprises Ltd stock appears to be Overvalued against its sector peers.

What is the 52-week high and low of TRANSPACT share price?

The 52-week high of TRANSPACT share price is ₹N/A and the 52-week low is ₹N/A.

What factors affect the Transpact Enterprises Ltd share price?

Key factors influencing TRANSPACT share price include quarterly earnings growth (Sales Growth: N/A%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).

Is Transpact Enterprises Ltd a good stock for long-term investment?

Transpact Enterprises Ltd shows a 5-year Profit Growth of 15.14% and an ROE of 2.22%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of 0.12 before investing in TRANSPACT shares.

How does Transpact Enterprises Ltd compare with its industry peers?

Transpact Enterprises Ltd competes with major peers in the Medical Equipment & Supplies. Investors should compare TRANSPACT share price P/E of 63.80x and ROE of 2.22% against the industry averages to determine competitive standing.

What is the P/E ratio of TRANSPACT and what does it mean?

TRANSPACT share price has a P/E ratio of 63.80x compared to the industry average of 47.87x. Investors pay ₹64 for every ₹1 of annual earnings.

How is TRANSPACT performing according to Bull Run's analysis?

TRANSPACT has a Bull Run fundamental score of 1.5/100, indicating concerns requiring careful analysis. This comprehensive rating is based on 15+ financial parameters.

What sector and industry does TRANSPACT belong to?

TRANSPACT operates in the Medical Equipment & Supplies industry. This classification helps understand the competitive landscape and sector-specific trends affecting Transpact Enterprises Ltd share price.

What is Return on Equity (ROE) and why is it important for TRANSPACT?

TRANSPACT has an ROE of 2.22%, which suggests challenges in generating returns from shareholders equity. ROE measures how efficiently Transpact Enterprises Ltd generates profits from shareholders capital.

How is TRANSPACT debt-to-equity ratio and what does it indicate?

TRANSPACT has a debt-to-equity ratio of 0.12, which indicates conservative financing with low financial risk.

What is TRANSPACT dividend yield and is it a good dividend stock?

TRANSPACT offers a dividend yield of 0.00%, meaning you receive ₹0.00 annual dividend for every ₹100 invested in Transpact Enterprises Ltd shares.

How has TRANSPACT share price grown over the past 5 years?

TRANSPACT has achieved 5-year growth rates of: Sales Growth N/A%, Profit Growth 15.14%, and EPS Growth 15.14%.

What is the promoter holding in TRANSPACT and why does it matter?

Promoters hold 0.13% of TRANSPACT shares, with 0.00% pledged. High promoter holding often indicates strong management confidence in Transpact Enterprises Ltd.

What is TRANSPACT market capitalisation category?

TRANSPACT has a market capitalisation of ₹6 crores, placing it in the Small-cap category.

How volatile is TRANSPACT stock?

TRANSPACT has a beta of N/A. A beta > 1 suggests the Transpact Enterprises Ltd stock is more volatile than the market, while a beta < 1 suggests it is less volatile.

What is TRANSPACT operating profit margin trend?

TRANSPACT has a 5-year average Operating Profit Margin (OPM) of -39.06%, indicating the company's operational efficiency.

How is TRANSPACT quarterly performance?

Recent quarterly performance shows Transpact Enterprises Ltd YoY Sales Growth of N/A% and YoY Profit Growth of 200.00%.

What is the institutional holding pattern in TRANSPACT?

TRANSPACT has FII holding of 0.00% and DII holding of 0.00%. Significant institutional holding often suggests professional confidence in the Transpact Enterprises Ltd stock.

HomeScreenerBattleWatchlist